Log In
BCIQ
Print this Print this
 

dolasetron (Anzemet)

  Manage Alerts
Collapse Summary General Information
Company Sanofi
DescriptionSerotonin (5-HT3) antagonist
Molecular Target Serotonin (5-HT) receptor
Mechanism of ActionSerotonin (5-HT) receptor antagonist
Therapeutic ModalitySmall molecule
Latest Stage of DevelopmentMarketed
Standard IndicationEmesis
Indication DetailsTreat and prevent post-operative nausea and vomiting (PONV)
Regulatory Designation
Partner

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
Total Number of DealsTotal Deal ValueTotal Upfront CashTotal Milestone Payments

1

0

0

0


 Deals Details
DateCompanies InvolvedDeal HeadlineTotal Deal ValueTotal Upfront CashTotal Milestone

12/14/2015

Undisclosed

Undisclosed

Undisclosed

Get a free BioCentury trial today